PHVS — Pharvaris NV Income Statement
0.000.00%
Last trade - 00:00- $1.53bn
- $1.15bn
- 37
- 19
- 64
- 34
Annual income statement for Pharvaris NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 25 | 54.1 | 86.7 | 96.9 | 146 |
| Operating Profit | -25 | -54.1 | -86.7 | -96.9 | -146 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26.1 | -42.7 | -75.7 | -99.8 | -132 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -26 | -42.7 | -76.3 | -101 | -134 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -26 | -42.7 | -76.3 | -101 | -134 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26 | -42.7 | -76.3 | -101 | -134 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.851 | -1.41 | -2.27 | -2.63 | -2.48 |